Zhejiang Yatai Pharmaceutical Co Ltd (002370) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Zhejiang Yatai Pharmaceutical Co Ltd (002370) has a cash flow conversion efficiency ratio of -0.006x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-6.29 Million ≈ $-920.75K USD) by net assets (CN¥1.12 Billion ≈ $164.06 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Zhejiang Yatai Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2007–2024)
This chart illustrates how Zhejiang Yatai Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 002370 total liabilities for a breakdown of total debt and financial obligations.
Zhejiang Yatai Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zhejiang Yatai Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Odfjell SE
OL:ODF
|
0.313x |
|
Hallador Energy Company
NASDAQ:HNRG
|
0.159x |
|
Nexpoint Residential Trust Inc
NYSE:NXRT
|
0.020x |
|
Platzer Fastigheter Holding AB (publ)
ST:PLAZ-B
|
0.017x |
|
Gujarat State Fertilizers & Chemicals Limited
NSE:GSFC
|
0.036x |
|
Southern Cross Electrical Engineering Ltd
AU:SXE
|
-0.039x |
|
Stratasys Ltd
NASDAQ:SSYS
|
0.006x |
|
Santacruz Silver Mining Ltd. Common Shares
NASDAQ:SCZM
|
0.096x |
Annual Cash Flow Conversion Efficiency for Zhejiang Yatai Pharmaceutical Co Ltd (2007–2024)
The table below shows the annual cash flow conversion efficiency of Zhejiang Yatai Pharmaceutical Co Ltd from 2007 to 2024. For the full company profile with market capitalisation and key ratios, see market value of Zhejiang Yatai Pharmaceutical Co Ltd.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥972.18 Million ≈ $142.26 Million |
CN¥24.35 Million ≈ $3.56 Million |
0.025x | -0.69% |
| 2023-12-31 | CN¥580.87 Million ≈ $85.00 Million |
CN¥14.65 Million ≈ $2.14 Million |
0.025x | -36.90% |
| 2022-12-31 | CN¥301.22 Million ≈ $44.08 Million |
CN¥12.04 Million ≈ $1.76 Million |
0.040x | +550.26% |
| 2021-12-31 | CN¥432.96 Million ≈ $63.36 Million |
CN¥-3.84 Million ≈ $-562.46K |
-0.009x | -132.93% |
| 2020-12-31 | CN¥660.41 Million ≈ $96.64 Million |
CN¥17.81 Million ≈ $2.61 Million |
0.027x | +130.62% |
| 2019-12-31 | CN¥633.06 Million ≈ $92.64 Million |
CN¥-55.74 Million ≈ $-8.16 Million |
-0.088x | -665.50% |
| 2018-12-31 | CN¥2.38 Billion ≈ $347.71 Million |
CN¥36.99 Million ≈ $5.41 Million |
0.016x | -72.20% |
| 2017-12-31 | CN¥2.28 Billion ≈ $333.36 Million |
CN¥127.59 Million ≈ $18.67 Million |
0.056x | +418.91% |
| 2016-12-31 | CN¥2.17 Billion ≈ $317.02 Million |
CN¥-38.05 Million ≈ $-5.57 Million |
-0.018x | -113.80% |
| 2015-12-31 | CN¥793.15 Million ≈ $116.06 Million |
CN¥100.93 Million ≈ $14.77 Million |
0.127x | +29.72% |
| 2014-12-31 | CN¥747.31 Million ≈ $109.36 Million |
CN¥73.31 Million ≈ $10.73 Million |
0.098x | +123.74% |
| 2013-12-31 | CN¥709.83 Million ≈ $103.87 Million |
CN¥31.12 Million ≈ $4.55 Million |
0.044x | +393.75% |
| 2012-12-31 | CN¥703.94 Million ≈ $103.01 Million |
CN¥-10.51 Million ≈ $-1.54 Million |
-0.015x | -122.80% |
| 2011-12-31 | CN¥745.30 Million ≈ $109.06 Million |
CN¥48.79 Million ≈ $7.14 Million |
0.065x | +1354.02% |
| 2010-12-31 | CN¥719.95 Million ≈ $105.35 Million |
CN¥-3.76 Million ≈ $-549.96K |
-0.005x | -101.76% |
| 2009-12-31 | CN¥229.79 Million ≈ $33.63 Million |
CN¥68.26 Million ≈ $9.99 Million |
0.297x | +603.47% |
| 2008-12-31 | CN¥198.69 Million ≈ $29.07 Million |
CN¥-11.72 Million ≈ $-1.72 Million |
-0.059x | -140.37% |
| 2007-12-31 | CN¥157.93 Million ≈ $23.11 Million |
CN¥23.08 Million ≈ $3.38 Million |
0.146x | -- |
About Zhejiang Yatai Pharmaceutical Co Ltd
Zhejiang Yatai Pharmaceutical Co., Ltd. researches, produces, sells, and exports pharmaceutical products in China and internationally. The company offers solid dosage, cephalosporin powder injection, and freeze-dried powder injection products. It also provides various antibiotic and non-antibiotic drugs. The company was founded in 1989 and is based in Shaoxing, China.